About Serac Life Sciences
Serac Life Sciences is a Healthcare company based in London (United Kingdom) founded in 2017. It operates as a molecular imaging devices are developed for arthritis diagnostics. Serac Life Sciences has raised $2.04 million across 7 funding rounds. Serac Life Sciences offers products and services including 99m Tc-maraciclatide and Seracam. Its focus areas include Life Sciences, Imaging Diagnostics and Nuclear Imaging. Its legal entity is SERAC IMAGING SYSTEMS LTD. Its competitors include Mercurius Health, Niowave, Mediso, Cubresa and PETsys Electronics and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Serac Life Sciences was founded in 2017 in London, United Kingdom, within the medical imaging sector. Radio-labeled tracers, such as maraciclatide, are developed to assess uptake in joints for diagnosing rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. A hybrid gamma camera is also produced for imaging small organs and structures, supporting targeted diagnostic operations in clinical settings.
- Headquarters London, United Kingdom
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website seraclifesciences.com
- Social LinkedIn
- Legal Name Serac Imaging Systems Ltd
- Date of Incorporation 21 Nov, 2017
- Jurisdiction LONDON, UNITED KINGDOM
- Total Equity Funding$2.04M (USD)
in 7 rounds
- Latest Funding Round$499.59K (USD), Seed
Feb 2022
Products & Services of Serac Life Sciences
Serac Life Sciences offers a comprehensive portfolio of products and services, including 99m Tc-maraciclatide and Seracam.
Radio-labelled agent for detecting endometriosis and arthritis in patients.
Hybrid camera for real-time molecular imaging at point-of-care settings.
Funding Insights of Serac Life Sciences
Serac Life Sciences has successfully raised a total of $2.04M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $499.59 thousand completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.04M
- Total Rounds 7
- Last Round Seed — $499,590
- First Round $376,740
(Jan 2019)
All 7 funding rounds of Serac Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $499,590 | Seed | – | – | – |
| Apr 2020 | $109,824 | Seed | – | – | – |
| Jan 2020 | $140,425 | Seed | – | – | – |
| May 2019 | $250,020 | Seed | – | – | – |
| Mar 2019 | $175,050 | Seed | – | – | – |
| Mar 2019 | $485,280 | Seed | – | – | – |
| Jan 2019 | $376,740 | Seed | – | – | – |
Timeline of Serac Life Sciences
3 dated milestones of Serac Life Sciences across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Serac Life Sciences is founded.
- Funding First funding round of $377K.
- Funding Latest funding round, Seed, of $500K.
Competitors of Serac Life Sciences
Serac Life Sciences has 9 listed competitors in our database, 3 of them funded. They include Mercurius Health, Niowave, Mediso, Cubresa and PETsys Electronics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mercuriushealth.com | 2013 | Porto Salvo, Portugal | – | – | Resources and training for radiotherapy and nuclear medicine are provided. | |
| niowaveinc.com | 2006 | United States | $9.95M | – | Devices and radioisotopes for nuclear imaging are provided by Niowave. | |
| mediso.com | 1990 | Budapest, Hungary | – | – | Nuclear medicine and hybrid imaging equipment | |
| cubresa.com | 2011 | Winnipeg, Canada | $4.5M | – | Nuclear imaging products | |
| petsyselectronics.com | 2013 | Oeiras, Portugal | – | – | Gamma ray detectors are developed for medical PET scanners. | |
| clearvascular.com | 2005 | The Woodlands, United States | $3.16M | – | Develops pharmaceutical products for treating cardiovascular conditions. | |
| bestcyclotron.com | 2009 | – | – | – | Provides comprehensive design and production solutions for commercial cyclotrons. | |
| cmr-naviscan.com | 2003 | Carlsbad, United States | – | – | High-resolution PET systems for breast cancer imaging are provided. | |
| mie-scintron.com | 1981 | Seth, Germany | – | – | Develops and supplies gamma cameras and PET systems for healthcare imaging. |
Detailed competitors of Serac Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Imaging Diagnostics
10 companies that operate in the same segment as Serac Life Sciences (Imaging Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | – | 91 | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M | – | – | |
Planar X-ray radiology products for diagnostic imaging are supplied. | 2000 | Oxford, Oxfordshire, United Kingdom | USD 43.43 M | USD 1.04 M | 50 | |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics. | 2004 | Jerusalem, Jerusalem District, Israel | USD 110.72 M | USD 13.02 M | 165 | |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | 2007 | Los Angeles, California, United States | USD 59.64 M | – | – | |
Portable wireless ultrasound systems are developed for medical imaging. | 2014 | Burnaby, British Columbia, Canada | USD 21.87 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Serac Life Sciences
Serac Life Sciences was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Serac Life Sciences is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Serac Life Sciences is a funded company, having raised a total of $2.04M across 7 funding rounds to date. The company's 1st funding round was a Seed of $376.74K, raised on Jan 2019.
Serac Life Sciences was founded in 2017 in London, United Kingdom, within the medical imaging sector. Radio-labeled tracers, such as maraciclatide, are developed to assess uptake in joints for diagnosing rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. A hybrid gamma camera is also produced for imaging small organs and structures, supporting targeted diagnostic operations in clinical settings.
Serac Life Sciences offers 99m Tc-maraciclatide and Seracam.
Serac Life Sciences operates through Serac Imaging Systems Ltd.